Skip to main navigation Skip to search Skip to main content

Acute lymphoblastic leukaemia patients treated with PEGasparaginase develop antibodies to PEG and the succinate linker

Research output: Contribution to journalArticlepeer-review

50 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Acute lymphoblastic leukaemia patients treated with PEGasparaginase develop antibodies to PEG and the succinate linker'. Together they form a unique fingerprint.
Sort by

Immunology and Microbiology

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science